{
    "nctId": "NCT06464913",
    "briefTitle": "Randomized Phase II Trial: Chest Wall RT Omission After Prosthetic Reconstruction",
    "officialTitle": "A Randomized Phase II Trial on Omission of Chest Wall Radiotherapy After Implant-Based Breast Reconstruction in Early Breast Cancer Patients",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 152,
    "primaryOutcomeMeasure": "Reconstruction failure rate (Capsular Contracture Grade III or higher)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Undergoes prosthetic reconstruction (including cold knife one-step prosthetic reconstruction or two-step expander-prosthetic reconstruction.);\n* Histologically confirmed invasive breast cancer patients with stage T1-2N1M0;\n* ECOG score of 0-1;\n* Indications for neoadjuvant therapy before surgery and adjuvant therapy after surgery.\n\nExclusion Criteria:\n\n* Other metabolically active malignant tumors;\n* Severe dysfunction of heart, lung, liver, kidney, or other vital organs;\n* Uncontrolled diabetes or other endocrine diseases;\n* Known allergy to radiotherapy or chemotherapy drugs;\n* Pregnant or lactating women.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}